The migraine drugs market is poised for significant growth in 2024, driven by advancements in treatments, increasing awareness, and rising prevalence of migraine cases worldwide. With an estimated 1 in 7 people globally suffering from migraines, the demand for effective therapeutic solutions continues to rise. This article delves into the factors fueling the growth of the migraine drugs market, highlighting key trends and innovations.